Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches

Show simple item record

dc.contributor.author Petersen, Steffen E en
dc.contributor.author Matthews, Paul M en
dc.contributor.author Bamberg, Fabian en
dc.contributor.author Bluemke, David A en
dc.contributor.author Francis, Jane M en
dc.contributor.author Friedrich, Matthias G en
dc.contributor.author Leeson, Paul en
dc.contributor.author Nagel, Eike en
dc.contributor.author Plein, Sven en
dc.contributor.author Rademakers, Frank E en
dc.contributor.author Young, Alistair en
dc.contributor.author Garratt, Steve en
dc.contributor.author Peakman, Tim en
dc.contributor.author Sellors, Jonathan en
dc.contributor.author Collins, Rory en
dc.contributor.author Neubauer, Stefan en
dc.date.accessioned 2014-01-29T03:27:41Z en
dc.date.issued 2013-05-28 en
dc.identifier.citation Journal of Cardiovascular Magnetic Resonance 15:10 pages Article number ARTN 46 28 May 2013 en
dc.identifier.issn 1097-6647 en
dc.identifier.uri http://hdl.handle.net/2292/21495 en
dc.description.abstract UK Biobank is a prospective cohort study with 500,000 participants aged 40 to 69. Recently an enhanced imaging study received funding. Cardiovascular magnetic resonance (CMR) will be part of a multi-organ, multi-modality imaging visit in 3–4 dedicated UK Biobank imaging centres that will acquire and store imaging data from 100,000 participants (subject to successful piloting). In each of UK Biobank’s dedicated bespoke imaging centres, it is proposed that 15–20 participants will undergo a 2 to 3 hour visit per day, seven days a week over a period of 5–6 years. The imaging modalities will include brain MRI at 3 Tesla, CMR and abdominal MRI at 1.5 Tesla, carotid ultrasound and DEXA scans using carefully selected protocols. We reviewed the rationale, challenges and proposed approaches for concise phenotyping using CMR on such a large scale. Here, we discuss the benefits of this imaging study and review existing and planned population based cardiovascular imaging in prospective cohort studies. We will evaluate the CMR protocol, feasibility, process optimisation and costs. Procedures for incidental findings, quality control and data processing and analysis are also presented. As is the case for all other data in the UK Biobank resource, this database of images and related information will be made available through UK Biobank’s Access Procedures to researchers (irrespective of their country of origin and whether they are academic or commercial) for health-related research that is in the public interest. en
dc.language English en
dc.publisher BIOMED CENTRAL LTD en
dc.relation.ispartofseries Journal of Cardiovascular Magnetic Resonance en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.biomedcentral.com/about/license http://www.sherpa.ac.uk/romeo/issn/1097-6647/ en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.rights.uri http://creativecommons.org/licenses/by/2.0/ en
dc.subject Science & Technology en
dc.subject Life Sciences & Biomedicine en
dc.subject Cardiac & Cardiovascular Systems en
dc.subject Radiology, Nuclear Medicine & Medical Imaging en
dc.subject Cardiovascular System & Cardiology en
dc.subject CARDIAC & CARDIOVASCULAR SYSTEMS en
dc.subject RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING en
dc.subject Cardiovascular magnetic resonance en
dc.subject Prospective cohort study en
dc.subject Population-based study en
dc.subject Nested-case control study en
dc.subject Biobank en
dc.subject LEFT-VENTRICULAR FUNCTION en
dc.subject ATHEROSCLEROSIS MESA en
dc.subject ASYMPTOMATIC INDIVIDUALS en
dc.subject RISK-FACTORS en
dc.subject SUBCLINICAL ATHEROSCLEROSIS en
dc.subject DIASTOLIC DYSFUNCTION en
dc.subject ALZHEIMERS-DISEASE en
dc.subject MRI en
dc.subject HYPERTROPHY en
dc.subject CARDIOMYOPATHY en
dc.title Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches en
dc.type Journal Article en
dc.identifier.doi 10.1186/1532-429X-15-46 en
pubs.volume 15 en
dc.description.version VoR - Version of Record en
dc.identifier.pmid 23714095 en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Review en
pubs.elements-id 404077 en
pubs.org-id Bioengineering Institute en
pubs.org-id ABI Associates en
pubs.org-id Medical and Health Sciences en
pubs.org-id Medical Sciences en
pubs.org-id Anatomy and Medical Imaging en
dc.identifier.eissn 1532-429X en
pubs.number ARTN 46 en
pubs.record-created-at-source-date 2014-01-29 en
pubs.dimensions-id 23714095 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics